Abstract
A trial of Biloptin, a new oral cholecystographic medium, on 60 cases is presented. The patients' reactions to the medium are analysed and discussed. The relative merits of oral and intravenous cholecystography are briefly reviewed.

This publication has 2 references indexed in Scilit: